DFV890
A Phase 1b, Open Label, Multi-center, Dose Optimization and Dose Expansion Study to Assess the Safety and Efficacy of DFV890 in Adult Patients With Myeloid Diseases
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sort by
Center of Excellence
- Accepting patients
- Show Principal Investigator
Center of Excellence
Stanford University Cancer Institute (Palo Alto)
Stanford, CA
- Accepting patients
Center of Excellence
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Mayo Clinic (Rochester)
Rochester, MN
- Accepting patients
Center of Excellence
Weill Cornell
New York, NY
- Accepting patients
Center of Excellence
- Accepting patients
500 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.